Brain-derived neurotrophic factor scales presynaptic calcium transients to modulate excitatory neurotransmission
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2303664121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Camille S Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 3729-7933. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Calcium. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NIGMS NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Brain-derived neurotrophic factor (BDNF) plays a critical role in synaptic physiology, as well as mechanisms underlying various neuropsychiatric diseases and their treatment. Despite its clear physiological role and disease relevance, BDNF’s function at the presynaptic terminal, a fundamental unit of neurotransmission, remains poorly understood. In this study, we evaluated single synapse dynamics using optical imaging techniques in hippocampal cell cultures. We find that exogenous BDNF selectively increases evoked excitatory neurotransmission without affecting spontaneous neurotransmission. However, acutely blocking endogenous BDNF has no effect on evoked or spontaneous release, demonstrating that different approaches to studying BDNF may yield different results. When we suppressed BDNF-Tropomyosin receptor kinase B (TrkB) activity chronically over a period of days to weeks using a mouse line enabling conditional knockout of TrkB, we found that evoked glutamate release was significantly decreased while spontaneous release remained unchanged. Moreover, chronic blockade of BDNF-TrkB activity selectively downscales evoked calcium transients without affecting spontaneous calcium events. Via pharmacological blockade by voltage-gated calcium channel (VGCC) selective blockers, we found that the changes in evoked calcium transients are mediated by the P/Q subtype of VGCCs. These results suggest that BDNF-TrkB activity increases presynaptic VGCC activity to selectively increase evoked glutamate release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 3729-7933.
- Department of Pharmacology, Vanderbilt University, Nashville, TN 37240-7933.
ORCID-Profile: Camille S Wang, Clara I McCarthy, Ege T Kavalali, Lisa M Monteggia
Förderung
- NIMH NIH HHS
- NIGMS NIH HHS
- NICHD NIH HHS
- HHS | NIH | National Institute of Mental Health
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Wang, C. S., McCarthy, C. I., Guzikowski, N. J., Kavalali, E. T., & Monteggia, L. M. (2024). Brain-derived neurotrophic factor scales presynaptic calcium transients to modulate excitatory neurotransmission. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2303664121
Vancouver
Wang CS, McCarthy CI, Guzikowski NJ, Kavalali ET, Monteggia LM. Brain-derived neurotrophic factor scales presynaptic calcium transients to modulate excitatory neurotransmission. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2303664121
BibTeX
@article{Wang2024,
author = {Wang, Camille S and McCarthy, Clara I and Guzikowski, Natalie J and Kavalali, Ege T and Monteggia, Lisa M},
title = {Brain-derived neurotrophic factor scales presynaptic calcium transients to modulate excitatory neurotransmission},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2303664121}
}
EUVIMED